SeaStar Medical Granted Nasdaq Listing Extension SeaStar Medical has received a reprieve from Nasdaq, extending its deadline to meet market value requirements to June 22, 2025. The company, which has faced liquidity challenges, plans to raise equity and demonstrate compliance with Nasdaq’s listing standards. The extension offers time to stabilize its financial standing.12